From: Ekki Plicht <ekki@plicht.de>
To: <rtty@contesting.com>
Date: Fri, 27 Sep 2002 23:46:21 +0000
Question:
What humanly single operator is able to work full 48hrs of a contest? Now
the
challenge is not only software, hardware, antennas and skills, but also
physical fitness.
It's a long while that I can remeber staying awake for 48hrs. 24 is no
problem, but 48?
Isn't it that the change of this rules provokes misuse, i.e. claiming single
op when indeed two or more ops were active?
Are results really comparable now for single ops? Before, every serious
player
had the chance to put 30hrs of full effort within the two days, thats
feasible. Now I have to compare my results to some (few?) others who worked
more or less the same hours than I did.
I don't know now how long I will be in the test, lets see how long I can
endure, hi hi.
I've been waiting for this to come up. See article below. Maybe we
should start drug testing?
And the other answer is: the strategy of choosing your sleep time.
73, doug
Boston Globe Online / Nation | World / Who needs sleep? New pill hits scene
Who needs sleep? New pill hits scene
By Carey Goldberg, Globe Staff, 9/22/2002
Just to see what it was like, the Cambridge computer programmer
stayed awake four straight days. He felt fine, he reported later, not
jittery, nicely focused. ''Imagine,'' he wrote in an e-mail, ''having
all the time you could want to goof off, knowing that you still have
just as much time as usual to spend on things you have to do.''
On the other hand, he added, ''if you lack imagination and run out of
things to do, you could end up bored real fast.''
The programmer, who asked that he not be identified, has not repeated
his ''little experiment,'' partly because of its questionable
legality. To stay awake, he borrowed a prescription drug, modafinil,
that is meant for narcoleptics, whose affliction causes excessive
sleepiness.
But he appears to have plenty of company in his desire to cheat time
by cheating sleep. In the three years since the drug was introduced
under the brand name Provigil for narcolepsy, sales have skyrocketed
to more than 250,000 prescriptions every three months, outstripping
the needs of the nation's estimated 150,000 narcoleptics.
Cephalon, the company that makes Provigil, says the seemingly excess
prescriptions mainly go to patients with other diseases that cause
fatigue.
But the buzz about modafinil as a potential elixir for millions of
''sleep when I die'' Americans has been building for months. Some
predict it may become the next Viagra or Prozac, the next ''lifestyle
drug.''
Sleep specialists hate that idea. Though modafinil causes few side
effects, they say, and though it shows little potential for addiction,
using it lightly to deprive the body of sleep, especially long-term,
is asking for trouble.
Nonetheless, talk about modafinil has been spreading, including
debates online and in print about whether such a pill could be a dream
come true for the underslept or a nightmare for a society that is
already running too fast.
On the Web site Metafilter.com, a group weblog with thousands of
chatty members, some loved the idea of Provigil.
''Heck, imagine making love all night, and still being alert at work
the next day!'' one posting read.
''Ever since I was a kid, I imagined having a magical clock that stops
time,'' read another.
But other posters worried. ''Drugs like this become a bit of an arms
race,'' wrote one. ''What do you do when all of your classmates are
taking Provigil and are more prepared for exams than you are? What do
you do when the job promotion goes to the keener putting in 16 hours a
day?''
A Washington Post reporter who tried staying up for two days on
Provigil gave it warm reviews in the paper, writing that ''Modafinil
may have the power to change Washington, D.C., and other high-powered
cities.''
But then, he wrote that story during a 40-hour period of
modafinil-enhanced wakefulness, so his judgment may have been
affected. Modafinil is believed to target areas of the brain
responsible for maintaining wakefulness more precisely than caffeine
or other stimulants, so it does not bring on a wired feeling or later
crash, but experts say it does not completely do away with all the
mental impairment that comes with sleep deprivation.
The military, too, has added to the attention paid modafinil by
reporting publicly that it has been testing the drug as ''performance
enhancement'' for combatants who must stay awake for days. It turned
out that they could function well for 40 hours, sleep eight hours, and
then get up and go another 40 hours before needing rest.
For all the talk, however, it remains unclear how much Provigil is
already being used by otherwise healthy sleep-cheaters.
Since the biotech firm Cephalon introduced Provigil in early 1999, the
drug's sales have jumped to a rate of $200 million per year, if
current sales keep up. Quarterly sales are up about 70 percent over
last year, and prescriptions are now running at the rate of 250,000 in
a three-month period, according to IMS Health, a health information
company.
Those numbers seem particularly high given that there are only an
estimated 150,000 narcoleptics in the country. And company officials
have acknowledged that perhaps only a quarter of the prescriptions are
going to narcoleptics.
But they also say they are not encouraging the use of Provigil by
people who do not need it, and they have no indication that it is
being widely abused.
Rather, they believe it is being prescribed ''off-label'' by doctors
to help patients with a variety of sleep disorders. And they are
seeking approval from the Food and Drug Administration to broaden
Provigil's label to include a wider variety of diseases that cause
fatigue.
However, there is anecdotal evidence of a nonmedical demand for
Provigil. For example, Dr. Richard J. Castriotta, a sleep expert at
the University of Texas, said a handful of people have asked him for a
Provigil prescription just to perk them up, but he has refused them.
Meanwhile, Web sites offer to sell Provigil without a prescription.
Modafinil may be OK for pilots or emergency workers, Castriotta said,
but it would be wrong ''to make that leap and say, `Well, gosh, why
can't I just sleep three hours a night as a way of life?' We don't
know enough about sleep deprivation to be able to determine what the
long-range effects might be, and that's very, very dangerous.''
He and other researchers predicted that in any case, because Provigil
is a controlled substance, and because it brings users no euphoria, it
is unlikely to be very widely abused.
But in a country where more than half the population is averaging more
than three cups of coffee per day, it does seem to have broad
potential appeal - particularly for the truckers and students and new
parents and others whose lives sometimes require all-nighters.
International Antiaging Systems, a company that has one of the
offshore pharmacy Web sites that sells modafinil, says its modafinil
sales have at least doubled in the last year, but it would not specify
the numbers involved.
A swath of studies, many sponsored by Cephalon, are underway to see if
Provigil might help patients with the fatigue caused by diseases
ranging from multiple sclerosis to attention deficit to sleep apnea to
depression. Much of the initial research shows tentative promise.
Another set of extensive studies is looking at whether modafinil will
help shift workers who have to stay awake at times when their bodies
beg to sleep. Their numbers are estimated at about 15 million.
Provigil's side effects tend to be mild, Cephalon says, with headache
and nausea the most common. It can also interact poorly with some
other drugs; in particular, it can reduce the effects of birth control
pills.
The prospect of Provigil or even better ''wake-enhancing'' drugs
gaining broad usage deeply concerns sleep specialists like Dr. Thomas
Scammell of Beth Israel Deaconess Medical Center, a leading authority
on modafinil.
''For society, it does bring up a really key question,'' he said.
''The simplest way to answer it is to say, `If I could give you a pill
that would take away your hunger, does that mean you shouldn't eat?'
Well, duh, you've got to eat and you know why, because you'll waste
away.''
''The problem,'' he added, ''is that the science of sleep research
hasn't reached the point that we can say, `If you don't get enough
sleep, X, Y, and Z will happen to you.''
However, a growing body of research does indicate that lack of sleep
may be even more harmful than previously thought. It may be
contributing to obesity by changing the metabolisms of the underslept
and to heart disease by causing low-grade inflammation.
But Americans are nonetheless sleeping less and working more,
according to the National Sleep Foundation. Its polls have found that
Americans sleep an average of about seven hours a night during the
work week, an hour and a half less than in 1900, and that one third of
adults are so sleepy in the daytime they could be dangerous. Federal
highway officials say lack of sleep causes 100,000 crashes a year.
To Dr. Daniel F. Kripke, a sleep expert at the University of
California at San Diego, excitement over a new drug like modafinil is
neither new nor very exciting - not to a veteran doctor who remembers
when cocaine and amphetamines spurred similar reactions.
''I think it is a promising drug but it has only been tested a
little,'' said Dr. Kripke, whose own research suggests that people who
sleep somewhat less than average may live longer.
''I'm very much in favor of broader scientific testing,'' he said,
''but I'm not in favor of people jumping off the deep end.''
Carey Goldberg can be reached at goldberg@globe.com.
This story ran on page A1 of the Boston Globe on 9/22/2002.
© Copyright 2002 Globe Newspaper Company.
|